Choosing the right CAR-T therapy for R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 4:14 2 years ago 101 Далее Скачать
The value of CAR-T cell therapy in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 0:51 2 years ago 112 Далее Скачать
CAR-T therapy versus autoSCT in DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:31 2 years ago 160 Далее Скачать
Bispecifics & CAR-T therapy in DLBCL: sequencing and selecting between these agents VJHemOnc – Video Journal of Hematology & HemOnc 1:04 1 year ago 143 Далее Скачать
Comparing the efficacy and curative potential of CAR-T therapy & bispecific antibodies in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:52 1 year ago 544 Далее Скачать
CAR-T therapy vs autologous transplantation in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 2:06 2 years ago 196 Далее Скачать
Exploring available third-line treatment options for R/R DLBCL: CAR-T, bispecifics, ADCs & mAbs VJHemOnc – Video Journal of Hematology & HemOnc 2:49 1 year ago 127 Далее Скачать
CAR-T therapy in R/R DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 3:05 4 years ago 35 Далее Скачать
Limitations of CAR T-cell therapy for DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:20 3 years ago 486 Далее Скачать
CAR-T moving forwards for r/r DLBCL VJHemOnc – Video Journal of Hematology & HemOnc 1:33 3 years ago 86 Далее Скачать
Who Should Receive CAR-T Cell Therapy for Lymphoma? HMP Education 21:03 4 years ago 1 208 Далее Скачать
An overview of CAR-T therapy in DLBCL and MCL VJHemOnc – Video Journal of Hematology & HemOnc 3:42 2 years ago 220 Далее Скачать
New algorithm for second-line DLBCL: the role of CAR-T therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:10 1 year ago 433 Далее Скачать
